Finally, loss of RB function is associated with compensatory induction of steady-state p16 protein levels [46], and therefore, we were able to use the same CLIA-certified test for p16 that is performed as a surrogate of HPV activity in cervical and oropharyngeal cancers. This evidence concerns the gene CDKN2A and oropharynx cancer.